Tumor cell dynamics and metastasis in advanced neuroblastoma

Pediatric Surgery International

Volumn 21, Issue 11, 2005, Pages 859-863

  Kuroda, Tatsuo ^a   Honna, Toshiro ^a   Morikawa, Nobuyuki ^a   Kitano, Yoshihiro ^a   Fuchimoto, Yasushi ^a   Terawaki, Kan ^a   Kumagai, Masaaki ^a   Tsunematsu, Yukiko ^a   Masaki, Hidekazu ^a   Matsuoka, Kentaro ^a   Saeki, Morihiro ^a  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Circulating tumor cell; Metastasis; Neuroblastoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE; ANTINEOPLASTIC AGENT;

ADRENAL TUMOR; ADVANCED CANCER; ARTICLE; BIOLOGY; BONE MARROW METASTASIS; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; DISSEMINATED CANCER; DYNAMICS; HUMAN; INFANT; MEDIASTINUM TUMOR; NEUROBLASTOMA; ONCOGENE C MYB; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; STEM CELL TRANSPLANTATION; TUMOR CELL;

BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; GENES, MYC; HUMANS; INFANT; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; NEUROBLASTOMA;

EID: 27944436987     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-005-1503-9     Document Type: Article

References (20)

1. Miller RW, Young JL Jr, Novakovic B (1995) Childhood cancer. Cancer 75(1suppl): 395-405
2. Kaneko M, Tsuchida Y, Uchino J et al (1999) Treatment results of advanced neuroblastoma with first Japanese study group protocol. Study Group of Japan for Treatment of Advanced Neuroblastoma. J Pediatr Hematol Oncol 21:190-197
3. Kuroda T, Saeki M, Mizutani S et al (1997) Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase- polymerase chain reaction. J Pediatr Surg 32:69-72
4. Kuroda T, Saeki M, Nakano M et al (2000) Surgical treatment of neuroblastoma with micrometastasis. J Pediatr Surg 35:1638-1642
5. Brodeur GM, Pritchard J, Berthold F et al (1993) Revision of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clini Oncol 11: 1466-1477
6. Shimada H, Umehara S, Monobe Y et al (2001) International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors; a report from the Children's Cancer Group. Cancer 92: 2451-2461
7. Cheung IY, Cheung NK (1997) Molecular detection of GAGE expression in peripheral blood and bone marrow: utility as a tumor marker for neuroblastoma. Clin Cancer Res 3:821-826
8. Miyajima Y, Kato K, Numata S et al (1995) Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer 75: 2757-2761
9. Burchill SA, Bradbury FM, Smith B et al (1994) Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Int J Cancer 57: 671-675
10. Mattano LA Jr, Moss TJ, Emerson SG (1992) Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 52: 4701-4705
11. Burchill SA, Bradbury FM, Smith B et al (1994) Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Int J Cancer 57: 671-675
12. Riley RD, Heney D, Jones DR et al (2004) A systematic review of molecular and biological tumor markers in neuroblastoma. Clin Cancer Res 10:4-12
13. Eggert A, Ikegami N, Kwiatkowski J et al (2000) high-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastoma. Clin Cancer Res 6:1900-1908
14. Fakhari M, Pullirsch D, Abraham D et al (2002) Selective upregulation of vascular endothelial growth factor receptors neurophillin-1 and -2 in human neuroblastoma. Cancer 94:258-263
15. Ara T, Kusafuka T, Inoue M et al (2000) Determination of imbalance between MMP-2 and T1MP-2 in human neuroblastoma by reverse-transcription polymerase chain reaction and its correlation with tumor progression. J Pediatr Surg 35:432-437
16. Blaheta RA, Hundemer M, Mayer G et al (2002) Expression level of neural cell adhesion molecule (NCAM) inversely correlates with the ability of neuroblastoma cells to adhere to endorhelium in vitro. Cell Commun Adhes 9: 131-147
17. Munchar MJ, Sharifah NA, Jamal R et al (2003) CD44s expression correlated with the International Neuroblastoma Pathology Classification (Shimada system) for neuroblastic tumors. Pathology 35: 125-129
18. Kotchetkov R, Cinatl J, Blaheta R et al (2003) Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes; a preclinical model. Int J Cancer 104: 36-43
19. Kaicker S, McCrudden KW, Beck L et al (2003) Thalidomide is anti-angiogenic in a xenograft of neuroblastoma. Int J Oncol 23: 1651-1655
20. Gong H, Pottgen C, Stuben G et al (2003) Arginine deliminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: potentiation by irradiation. Int J Cancer 106: 723-728